Clinical Trial Data Quality Hinges on Site-Level Management, Experts Emphasize at OCT Medical Devices 2025
Key Insights
Clinical investigation experts at OCT Medical Devices (search) 2025 conference highlight that regulatory compliance challenges primarily originate at the trial site level, emphasizing the critical role of data quality.
Strong sponsor presence and proper site training are essential for ensuring high-quality data collection and regulatory compliance, according to Medaxis (search) medical expert Mark Cregan.
Contipro (search)'s Head of Regulatory Affairs Pavel Kusnierik stresses the importance of CRO partnerships in maintaining data integrity and addressing process deficiencies during clinical investigations.
Industry experts at the Outsourcing Clinical Trials (OCT) Medical Devices 2025 conference in Munich have emphasized that the foundation of successful clinical investigations lies in robust site-level data management and oversight. The conference, held on January 28-29, brought together key stakeholders to address critical challenges in medical device clinical trials.
Site Management and Data Quality
Mark Cregan, medical expert at Medaxis (search), highlighted the direct correlation between site-level processes and regulatory compliance. "The quality of data defines all your regulatory compliance, and that really depends upon the sponsor to have a good presence at the site," Cregan explained. He emphasized that proper documentation of serious adverse events and other critical data points requires well-trained and supported site staff.
Role of Clinical Research Organizations
Pavel Kusnierik, head of regulatory affairs at Contipro (search), outlined the crucial role of Clinical Research Organizations (CROs) in maintaining investigation quality. He stressed that CROs must serve as active partners, capable of identifying and addressing potential issues before they compromise data integrity.
Managing Clinical Investigation Challenges
Several common challenges can impact data quality during clinical investigations:
- Patient enrollment outside inclusion/exclusion criteria
- Procedural deviations affecting data collection
- Compliance issues in documentation processes
Kusnierik emphasized that CROs must be prepared to take decisive action when necessary: "You need to think about the patient benefit, and in some cases, this may necessitate a rethink and even a restart of processes to ensure good outcomes for the overall clinical investigation."
Best Practices for Quality Assurance
To maintain high standards in clinical investigations, experts recommend:
- Regular sponsor presence at trial sites
- Comprehensive site staff training programs
- Clear communication channels between sponsors, CROs, and sites
- Proactive monitoring of data collection processes
- Immediate intervention when quality issues arise
The discussions at OCT Medical Devices (search) 2025 underscore the industry's growing focus on quality management at the site level as a cornerstone of successful clinical investigations. This approach aims to ensure both regulatory compliance and meaningful clinical outcomes.